Bernard Murphy
Moderator
This is a company that promised to revolutionize hundreds of tests using a pinprick and a single drop of blood. They soared to a $9B valuation but have increasingly come under government and market scrutiny regarding the substance of their claims and the safety of their lab tests. A reminder that we in general and the market in particular are predisposed maybe a little more than we should be to believe in miracles, both medical and financial.
Caveat emptor.
Theranos Sounded Too Good to Be True?and It Is - The Daily Beast
Caveat emptor.
Theranos Sounded Too Good to Be True?and It Is - The Daily Beast